Caplight Directory>Companies>Duo Oncology-preview>Duooncology


Duo Oncology

Duo Oncology

Private
Pittsburgh, PennsylvaniaN/Ahttps://www.duooncology.com/

Last Round

Seed

Aug 7, 2025

Total Funding Raised

$9.45M

Momentum Score

25 /100

Company Overview

Duo Oncology is a biotechnology company that develops tumor-responsive nanomedicines to treat difficult-to-target cancers.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Duo Oncology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Duo Oncology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedAug 7, 2025
GrantDec 12, 2024
AcceleratorMar 21, 2024
SeedAug 7, 2023
GrantApr 17, 2023
Seed
Feb 19, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Sam Rothstein

Chief Executive Officer

Executive Team

Katie Eichinger

Chief Operating Officer

Executive Team

Duo Oncology Investors

Notable investors and investment history

InvestorRounds
National Cancer InstituteGrant
LifeX GlobalSeed
Innovation WorksSeed
Ulu VenturesSeed
SeedFolioSeed
NuFundSeed
National Cancer Institute I-CorpsAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 7, 2025

    $3M round led by SeedFolio.

  • Jun 1, 2025

    Monthly visitors increased 88% MoM, from 692 to 1.3K.

View all signals

Duo Oncology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Duo Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Duo Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range4
Year Founded2020
Last FundingAug 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.